Save
VULVAR CANCER WITH POSITIVE NODES OF THE GROIN - PELVIC LYMPHADENECTOMY, ADJUVANT RADIOTHERAPY OR RADIOCHEMOTHERAPY?
ESGO eAcademy, Sven Mahner, 39124
ISOLATED TUMOUR CELLS AND MICROMETASTASES: HOW TO DEAL WITH IT?
ESGO eAcademy, Nadeem Abu Rustum, 39125
PITFALLS IN SENTINEL NODE DETECTION IN VULVAR CANCER: AN IN DEPTH ANALYSIS OF FALSE NEGATIVE CASES
ESGO eAcademy, Maaike Oonk, 39126
QUALITY OF LIFE AND SURVIVAL AFTER SN BIOPSY. RESULTS OF THE SENTICOL II, RANDOMIZED TRIAL
ESGO eAcademy, Patrice Mathevet, 39127
ENDOMETRIAL CANCER: PREOPERATIVE ULTRASOUND ASSESSMENT TO TAILOR SURGERY
ESGO eAcademy, Elisabeth Epstein, 39118
NEW IMAGING TECHNOLOGY IN OVARIAN CANCER
ESGO eAcademy, Ate G.J. van der Zee, 39119
ULTRASOUND VERSUS MRI IN CERVICAL CANCER STAGING AND INDIVIDUAL TREATMENT PLANNING
ESGO eAcademy, Daniela Fischerova, 39120
IMAGING PRE-INVASIVE TUBAL LESIONS IN HIGH RISK POPULATIONS
ESGO eAcademy, Jessica McAlpine, 39112
TUBAL PATHOLOGY IN BRCA 1 AND 2 MUTATION CARRIERS
ESGO eAcademy, Ronny Drapkin, 39114
CONTROVERSIES IN ADJUVANT THERAPY
ESGO eAcademy, Wui-Jin Koh, 39115
CONTROVERSIES IN THE MANAGEMENT OF ADVANCED CASES IN VULVAR CANCER
ESGO eAcademy, Lukas Rob, 39116
CURRENT STATUS OF SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER
ESGO eAcademy, Ate G.J. van der Zee, 39117
IMPLICATIONS FOR FUTURE RESEARCH
ESGO eAcademy, Ignance Vergote, 39341
REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - US VIEW
ESGO eAcademy, Sean C. Dowdy, 39339
REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - EUROPEAN VIEW
ESGO eAcademy, Nicoletta Colombo, 39338
COMPLICATIONS AND MORTALITY ASSOCIATED WITH PRIMARY OPTIMAL CYTOREDUCTION
ESGO eAcademy, Angelo Maggioni, 39109
NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER
ESGO eAcademy, Ignance Vergote, 39110
PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
ESGO eAcademy, Giovanni Scambia, 39111
GUIDELINES AND LEVEL OF EVIDENCE FROM THE TRIALS
ESGO eAcademy, John A Green, 39105
Treatment-Surgery-Lymph Nodes- Radiotherapy- Chemotherapy- Individualization- Recurrence
ESGO eAcademy, Paolo Zola, 39106
WHAT IS ENDOMETRIAL CANCER - PATHOLOGY, MOLECULAR CHARACTERISATION ETC, EPIDEMIOLOGY
ESGO eAcademy, Glenn McCluggage, 39108
IS THE THERAPY-FREE INTERVAL OF 6 MONTHS STILL A USEFUL MODEL FOR GUIDING 2NDLINE OR HIGHER THERAPIES IN OVARIAN CANCER?
ESGO eAcademy, Daniel U. Reimer, 39100
TREATMENT CONSIDERATIONS IN CERVICAL CANCER WITH PELVIC RECURRENCE AFTER ADJUVANT OR PRIMARY RADIOCHEMOTHERAPY
ESGO eAcademy, Stefano Greggi, 39101
TREATMENT CONSIDERATIONS IN PATIENTS WITH RECURRENT CARCINOMATOSIS AFTER SEVERAL LINES OF CHEMOTHERAPY AND SUBILEUS/ILEUS
ESGO eAcademy, Philipp Harter, 39102
TREATMENT CONSIDERATIONS IN VULVA CARCINOMA WITH LOCO-REGIONAL RECURRENCE
ESGO eAcademy, Ate G.J. van der Zee, 39103
PROGRESS IN RISK PREDICTION, DIAGNOSIS AND SCREENING FOR OVARIAN CANCER
ESGO eAcademy, Ian Jacobs, 39099
Vaginal Trachelectomy + Laparoscopic LND
ESGO eAcademy, Achim Schneider, 39134
Surgical Staging of Cervical Carcinoma and Extraperitoneal LND
ESGO eAcademy, Eric Leblanc, 39135
ROBOTIC SURGERY FOR THE MANAGEMENT OF CERVICAL CANCER
ESGO eAcademy, Angelo Maggioni, 39136
Vulva Cancer: VFR and Recostruction with Flaps
ESGO eAcademy, Nadja Dornhöfer, 39138
SLN in Vulvar Cancer
ESGO eAcademy, Ate G.J. van der Zee, 39139
PALLIATIVE AND END OF LIFE CARE IN GYNECOLOGICAL CANCER - GOING BEYOND THE PHYSICAL
ESGO eAcademy, Mari Lloyd-Williams, 39097
PALLIATIVE CARE - END OF LIFE CARE IN GYNECOLOGICAL CANCER : ASPECTS OF CLINICAL PRACTICE
ESGO eAcademy, Johan Menten, 39098
Cancer: A Family Affair
ESGO eAcademy, Lea Baider, 48149
Anxiety and Adjustment Disorders in Cancer Patients
ESGO eAcademy, Katalin Muszbek, 48150
Loss, Grief and Bereavement
ESGO eAcademy, David Kissane, 48151
Palliative Care for the Psycho-Oncologist
ESGO eAcademy, William Breitbart, 48152
Ethical Implications of Psycho-Oncology
ESGO eAcademy, Antonella Surbone, 48153
Psychosocial Interventions: Evidence and Methods for Supporting Cancer Patients
ESGO eAcademy, Maggie Watson & Barry Bultz, 48154
Psychosocial Assessment in Cancer Patients
ESGO eAcademy, Uwe Koch & Anja Mehnert, 48155
Communication and Interpersonal Skills in Cancer Care
ESGO eAcademy, Walter F. Baile, 48156
Distress Management in Cancer
ESGO eAcademy, Jimmie C. Holland, 48157
Depression and Depressive Disorders in Cancer Patients
ESGO eAcademy, Luigi Grassi & Yosuke Uchitomi, 48158
Guideliness and Evidence from the Trials about Follow up
ESGO eAcademy, Elisa Piovano, 45901
PERSONALIZED SURGICAL CARE FOR CERVICAL CANCER
ESGO eAcademy, Rene H.M. Verheijen, 39091
SENTINEL NODE CONCEPT AND RELEVANCE OF DETECTION OF MICROMETASTASES
ESGO eAcademy, David Cibula, 39092
(NEO-) ADJUVANT CHEMOTHERAPY AND CERVICAL CANCER
ESGO eAcademy, Roberto Angioli, 39093
NO HEALTH WITHOUT MENTAL HEALTH: THE IMPORTANCE OF PSYCHOSOCIAL CARE IN GYNAECOLOGICAL CANCER
ESGO eAcademy, Maggie Watson, 39083
PHYSICAL ACTIVITY AFTER CANCER
ESGO eAcademy, Freerk T. Baumann, 39084
POPULATION BASED OUTCOMES OF EARLY STAGE OVARIAN ENDOMETRIOID CARCINOMA (OEC) IN BRITISH COLUMBIA
ESGO eAcademy, Aalok Kumar, 39086
A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF WEEKLY PACLITAXEL PLUS TREBANANIB OR PLACEBO IN WOMEN WITH RECURRENT OVARIAN CANCER: TRINOVA-1
ESGO eAcademy, Bradley Monk, 39087
ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER
ESGO eAcademy, Eric Pujade-Lauraine, 39088
RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.
ESGO eAcademy, Fharat Raja, 39089
PELVIC LYMPHADENECTOMY IMPROVES SURVIVAL IN CERVICAL CANCER PATIENTS WITH LOW VOLUME DISEASE IN THE SENTINEL NODE, A RETROSPECTIVE MULTICENTRE COHORT STUDY
ESGO eAcademy, Afra Zaal, 39090
Principles of Total Omentectomy
ESGO eAcademy, Di Donato Violante, 39128
Splenectomy and Distal Pancreatectomy in Ovarian Cancer
ESGO eAcademy, Eric Leblanc, 39129
Staging Lymphadenectomy
ESGO eAcademy, Andreas Widschwendter, 39130
Modified Posterior Exenteration
ESGO eAcademy, David Cibula, 39131
Liver Mobilization and Diaphragm Peritonectomy
ESGO eAcademy, Nadeem Abu Rustum, 39132
ROBOTIC STAGING
ESGO eAcademy, K. Rainer Kimmig, 39133
HPV SELF-SAMPLING
ESGO eAcademy, Paolo Giorgi Rossi, 39077
HPV TESTING IN PRIMARY SCREENING IN LOW RESOURCES SETTINGS
ESGO eAcademy, Maribel Almonte, 39078
HPV TESTING/GENOTYPING IN PRIMARY SCREENING IN DEVELOPED COUNTRIES
ESGO eAcademy, Mario Sideri, 39079
ADAPTIVE BRACHYTHERAPY AND BEYOND IN CERVICAL CANCER TREATMENT
ESGO eAcademy, Christine Haie-Meder, 39073
LOCO REGIONAL RECURRENCES IN GYNECOLOGICAL MALIGNANCIES : TREATMENT COMPLICATIONS AND COST ANALYSIS
ESGO eAcademy, Alessandro Urgesi, 39074
HEALTH AND WELLBEING IN WOMEN
ESGO eAcademy, Peter Kinderman, 39075
PATIENT AND CLINICIAN PERSPECTIVES: A MEDICAL HUMANITIES VIEW OF THE CONSULTATION IN GYNAE ONCOLOGY.
ESGO eAcademy, Jane Macnaughton, 39076
FUNCTIONAL MR AS A BIOMARKER OF RESPONSE TO TREATMENT IN LOCALLY ADVANCED CERVICAL CANCER
ESGO eAcademy, Margaret Hall-Craggs, 45897
1ST LINE TREATMENT (SURGERY AND SYSTEMIC THERAPY) - STATE OF THE ART 2013
ESGO eAcademy, Christian Marth, 39070
PLATINUM SENSITIVE RELAPSE: THE ROLE OF SURGERY AND CURRENT STATE OF THE ART OF SYSTEMIC THERAPY
ESGO eAcademy, Philipp Harter, 39071
STATE-OF-THE ART AND NEW OPTIONS IN THE TREATMENT OF RELAPSE WITHIN A YEAR AFTER 1STLINE
ESGO eAcademy, Domenica Lorusso, 39072
PERSONALIZED THERAPY IN GYNAECOLOGIC ONCOLOGY: BIOLOGY, STRATEGY, AND ASSESSMENT
ESGO eAcademy, Anil Sood, 39064
PERSPECTIVES ON RECEPTOR TYROSINE KINASE ACTIVATION IN OVARIAN CANCER AND ITS RELATIONSHIP TO PERSONALISED MEDICINE
ESGO eAcademy, Hani Gabra, 39065
EUTHANASIA
ESGO eAcademy, Johan Menten, 39066
HARMONIZATION OF RADICAL HYSTERECTOMY CLASSIFICATION
ESGO eAcademy, David Cibula, 39067
HIPEC ROLE IN OVARIAN CANCER
ESGO eAcademy, Anna Fagotti, 39068
MANAGEMENT OF LOCALLY ADVANCED CERVICAL CANCER
ESGO eAcademy, Denis Querleu, 39069
PHASE III TRIAL OF EVERY-3-WEEKS PACLITAXEL VS. DOSE DENSE WEEKLY PACLITAXEL WITH CARBOPLATIN +/- BEVACIZUMAB IN EPITHELIAL OVARIAN, PERITONEAL, FALLOPIAN TUBE CANCER: GOG 262 (NCT01167712)
ESGO eAcademy, JOHN CHAN, 39058
AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL OF STANDARD FRONTLINE CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER
ESGO eAcademy, Andreas Du Bois, 39059
PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF WEEKLY FARLETUZUMAB WITH CARBOPLATIN/TAXANE IN SUBJECTS WITH PLATINUM-SENSITIVE OVARIAN CANCER IN FIRST RELAPSE
ESGO eAcademy, Ignance Vergote, 39061
Robotic Surgery in Gynaecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module I: Common Iliac, Subaortic and Presacral Nodes
ESGO eAcademy, K. Rainer Kimmig, 38736
Robotic Surgery in Gynecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module III: Upper Paravisceral - Prespinal and Preischaidic Nodes
ESGO eAcademy, K. Rainer Kimmig, 38738
Robotic Surgery in Gynaecology - Therapeutic Lymphadenectomy of the Pelvic Nodes (TPL1) - Module II: Lower Paravisceral and External Iliac Nodes
ESGO eAcademy, K. Rainer Kimmig, 38737
Debulking Procedures - Splenectomy with Total Omentectomy
ESGO eAcademy, David Cibula, 50935
Debulking Procedures - Liver Mobilisation and Diaphragm Stripping
ESGO eAcademy, David Cibula, 50936
Designing Clinical Trials with Patient - Reported Outcomes as Trials Endpoits
ESGO eAcademy, Eva Greimel, 34943
When and How Should Patient- Reported Outcome be Measured and Incorporated into Clinical Trials
ESGO eAcademy, Felix Hilpert, 34948
GYN Translational Research Organisation in Europe
ESGO eAcademy, MICHAEL BIRRER, 34944
What is EUTROC?
ESGO eAcademy, Jalid Sehouli, 34946
What is ENGOT?
ESGO eAcademy, Andreas Du Bois, 34941
What is GCIG?
ESGO eAcademy, Eric Pujade-Lauraine, 34942
Sum-Up of Visions and Missions
ESGO eAcademy, Karina Dahl Steffensen, 34940
Robot-Assisted Laparoscopic Nerve Sparing - Okabayashi's Radical Hysterectomy according to Shingo Fujii's Technique
ESGO eAcademy, Angelo Maggioni, 33613
Easy Learning Hysterectomy - Panniculectomy to Facilitate Abdominal Hysterectomy and Staging
ESGO eAcademy, N. R. Abu-Rustum & B. Mehrara, 33612
Abdominal Procedures in Gynaecological Oncology - Extrafascial Hysterectomy
ESGO eAcademy, David Cibula & Tomas Herrmann, 33611
Robotic Surgery in Gynaecology - Therapeutic Paraaortic Lymphadenectomy (TPL2) - Module V1: Infrarenal/Supramesenteric Periaortic Nodes
ESGO eAcademy, K. Rainer Kimmig, 95405
Closed and Published Trials - Cervical Cancer
ESGO eAcademy, Bradley Monk, 41673
An Introduction to Patient Reported Outcomes in Clinical Trials
ESGO eAcademy, Antonio Gonzalez, 41672
Closed and Published Trials - Ovarian Cancer
ESGO eAcademy, Bradley Monk, 41674
ASCO/ESMO/IGCS 2012 Pivotal Data Critique. How These Data Impact the State of the Art
ESGO eAcademy, Nicoletta Colombo, 42271

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings